[
    [
        {
            "time": "2021-01-05",
            "original_text": "FIDELITY INVESTMENT TRUST减持泰格医药(03347)17.4万股，每股作价约179.26港元 减持股份",
            "features": {
                "keywords": [
                    "FIDELITY INVESTMENT TRUST",
                    "减持",
                    "泰格医药",
                    "17.4万股",
                    "179.26港元"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "FIDELITY INVESTMENT TRUST减持泰格医药(03347)17.4万股，每股作价约179.26港元 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-30",
            "original_text": "医疗健康行业基金4Q分析：四季度医药板块配置环比下降 机构持仓进一步集中",
            "features": {
                "keywords": [
                    "医疗健康",
                    "基金",
                    "4Q",
                    "医药板块",
                    "配置下降",
                    "机构持仓集中"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医疗健康行业基金4Q分析：四季度医药板块配置环比下降 机构持仓进一步集中",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-08",
            "original_text": "瑞银：上调泰格医药(03347)目标价79.9%至268港元 评级“买入”",
            "features": {
                "keywords": [
                    "瑞银",
                    "上调",
                    "泰格医药",
                    "目标价",
                    "268港元",
                    "买入"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "瑞银：上调泰格医药(03347)目标价79.9%至268港元 评级“买入”",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-10",
            "original_text": "高瓴资本概念股市值普遍调整，恩捷股份、凯莱英、公牛集团、甘李药业、泰格医药均大跌",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股市值调整",
                    "恩捷股份",
                    "凯莱英",
                    "公牛集团",
                    "甘李药业",
                    "泰格医药",
                    "大跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股市值普遍调整，恩捷股份、凯莱英、公牛集团、甘李药业、泰格医药均大跌",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-25",
            "original_text": "医药行业Q42020持仓分析：医药仓位有所回落 核心资产持续加强",
            "features": {
                "keywords": [
                    "医药行业",
                    "Q42020",
                    "持仓分析",
                    "医药仓位回落",
                    "核心资产加强"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业Q42020持仓分析：医药仓位有所回落 核心资产持续加强",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-01-12",
            "original_text": "大行评级|瑞银：上调泰格医药(3347.HK)目标价至268港元评级“买入”",
            "features": {
                "keywords": [
                    "大行评级",
                    "瑞银",
                    "上调",
                    "泰格医药",
                    "目标价",
                    "268港元",
                    "买入"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大行评级|瑞银：上调泰格医药(3347.HK)目标价至268港元评级“买入”",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-15",
            "original_text": "A股午盘综述：上证指数跌1.2%，创业板指跌2.39%",
            "features": {
                "keywords": [
                    "A股",
                    "午盘综述",
                    "上证指数",
                    "跌1.2%",
                    "创业板指",
                    "跌2.39%"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股午盘综述：上证指数跌1.2%，创业板指跌2.39%",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-18",
            "original_text": "【行情】港股生物医药板块集体下挫，泰格医药跌5.9%，康希诺生物跌5.2%，药明康德跌5.1%，药明生物跌4.8%，百济神州跌4% 连续下跌",
            "features": {
                "keywords": [
                    "港股",
                    "生物医药板块",
                    "集体下挫",
                    "泰格医药",
                    "康希诺生物",
                    "药明康德",
                    "药明生物",
                    "百济神州",
                    "连续下跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【行情】港股生物医药板块集体下挫，泰格医药跌5.9%，康希诺生物跌5.2%，药明康德跌5.1%，药明生物跌4.8%，百济神州跌4% 连续下跌",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-20",
            "original_text": "【权益变动】泰格医药(03347-HK)被FIDELITY INVESTMENT TRUST减持17.4万股 减持股份",
            "features": {
                "keywords": [
                    "权益变动",
                    "泰格医药",
                    "FIDELITY INVESTMENT TRUST",
                    "减持",
                    "17.4万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【权益变动】泰格医药(03347-HK)被FIDELITY INVESTMENT TRUST减持17.4万股 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-28",
            "original_text": "中信建投五大研究团队复盘2020年四季度公募基金持仓",
            "features": {
                "keywords": [
                    "中信建投",
                    "研究团队",
                    "复盘",
                    "2020年四季度",
                    "公募基金持仓"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中信建投五大研究团队复盘2020年四季度公募基金持仓",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-01-22",
            "original_text": "泰格医药(03347.HK)遭NINETEYONEUK减持12.18万股 减持股份",
            "features": {
                "keywords": [
                    "泰格医药",
                    "NINETEYONEUK",
                    "减持",
                    "12.18万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "泰格医药(03347.HK)遭NINETEENUK减持12.18万股 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]